Patent · US Active

Polymorphs of 3-O-(3′,3′-dimethylsuccinyl)betulinic acid di-N-methyl-D-glucamine

US7799768B2 · kind B2 · utility

1Cited by

8References

28Claims

0Family size

Assignee

Myrexis, Inc. · US

Inventors

Mike H. O'Neill · Greenville, US
Gary Sweetapple · Madison, US
Randall M. Walker · Willoughby, US
Arndt Hausherr · Mainz, DE
Gunter Koch · Bad Kreuznach, DE
David Martin · Shawnee, US

Key dates

Filing date	Apr 12, 2006
Grant date	Sep 21, 2010
Priority date	—
Expiry date	Sep 22, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to crystalline polymorphs of 3-O-(3′,3′-dimethylsuccinyl)betulinic acid di-N-methyl-D-glucamine salt (“DSB•2NMG)”), pharmaceutical compositions of the same and use of the same as an active pharmaceutical agent in the treatment of HIV related disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.